AnalystsChris RaymondChris Raymond's Stock Forecasts
AnalystsChris Raymond
Sectors:
Industries:
Analyst Ranking
Top 30%
#1509 out of 5100 analysts
Average Return
+35.62%
Win Rate
67%6 out of 9
Risk vs Reward
Poor
Good
Chris Raymond's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cogent Biosciences IncCOGT | +156.42% | $13.08 | $33.54 | 2025-09-03 - 2025-11-14 | Strong Buy |
Monopar TherapeuticsMNPR | +115.41% | $36.21 | $78.00 | 2025-09-03 - 2025-11-14 | Strong Buy |
Sionna Therapeutics IncSION | +50.71% | $24.55 | $37.00 | 2025-09-03 - 2025-11-14 | Strong Buy |
Tyra Biosciences IncTYRA | +27.68% | $12.32 | $15.73 | 2025-09-03 - 2025-11-14 | Strong Buy |
Nuvalent IncNUVL | +21.32% | $79.54 | $96.50 | 2025-09-03 - 2025-11-14 | Buy |
Chris Raymond Analyst Color
Get additional color on Chris Raymond's coverage of popular stocks
Chris Raymond's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | 3 | Buy | $123.00 | +57.69% | Downgrades | 3 days ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $45.00 | +21.62% | Initiates Coverage On | 2 months ago |
Tyra Biosciences IncTYRA | 1 | Strong Buy | $35.00 | +122.50% | Initiates Coverage On | 2 months ago |
Nuvalent IncNUVL | 1 | Buy | $105.00 | +8.81% | Initiates Coverage On | 2 months ago |
Kalaris Therapeutics IncKLRS | 1 | Strong Buy | $23.00 | +321.25% | Initiates Coverage On | 2 months ago |
Cogent Biosciences IncCOGT | 1 | Strong Buy | $30.00 | -10.55% | Initiates Coverage On | 2 months ago |
Biohaven LtdBHVN | 1 | Strong Buy | $75.00 | +803.61% | Initiates Coverage On | 2 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.